ePrivacy and GPDR Cookie Consent by TermsFeed Generator

DEFERASIROX MSN

360MG TBL FLM 30

SÚKL code 0228229
Name of the product DEFERASIROX MSN
_MA_MEDICATION_DETAIL_INFO_MED_NAME i DEFERASIROX MSN
Supplement 360MG TBL FLM 30
Strenght 360MG
Pharmaceutical form Film-coated tablet
Package 30
Route Oral use
Language of the pack Czech
Wrap type Blister
Legal status na lékařský předpis
Active substance DEFERASIROX (DEFERASIROXUM)
ATC group V03AC03
ATC group name DEFERASIROX

Marketing authorisation information

Registration Number 19/ 033/18-C
Type of MA A mutual recognition procedure (MRP, DCP), where CZ is Concerned member state
MA status B - medicinal product after change, may be placed on the market for the period of 6 months (Placed on the market till) and used until expiration, not later than till the end of validity of the marketing authorisation (Valid till)
Placed on the market till 30. 04. 2023
MA Holder Vivanta Generics s.r.o., Praha
MA Holder country ČESKÁ REPUBLIKA
Actual MA holder MSN LABS EUROPE Limited, Paola
Actual MA holder country MALTA

Back to list